News: SRX Sirtex Medical seeks trading halt; receives letter representating proceeding against co

Jan 31 (Reuters) - Sirtex Medical Ltd (SRX)

• Received a letter from a law firm foreshadowing commencement of a representative proceeding against company
• Is considering foreshadowed claim, and taking legal advice, but considers that claim is material to company
• Trading halt is requested to be effected immediately to ensure that market trades only on a fully informed basis
• Letter based on alleged breaches of its continuous disclosure obligations, alleged misleading and deceptive conduct
• Allegations arising out of a statement made by co on 24 August 2016 that company would achieve "double digit dose sales growth" in FY17